Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nephrol Dial Transplant ; 27(2): 820-4, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21652544

ABSTRACT

BACKGROUND: We hypothesized that supplementing a higher mass of renal parenchyma from adult donors, and their younger age, would improve graft function in paediatric recipients. METHODS: We calculated estimated glomerular filtration rate (eGFR; Schwartz formula) and absolute glomerular filtration rate (absGFR) in 57 renal-grafted children (1995-2007) aged 3.1-17.9 years, weighing 12.9-85.0 kg, on discharge from the hospital after transplantation (TPL), 1 year after TPL and at the last follow-up (1.5-11.7 years after TPL). We correlated their eGFR with the individual ratio between the donor and the recipient body weight at the time of TPL (donor/recipient body weight ratio; D/R BWR), and we evaluated the effect of the donor and the actual recipient body weight on the eGFR and absGFR. RESULTS: The D/R BWR varied from 0.65 to 5.23. We found a significant positive correlation between D/R BWR and eGFR at discharge from the hospital (P < 0.001), 1-year post-TPL (P < 0.001) and at the last follow-up (P < 0.05). Using multiple linear regression analyses, we found that both eGFR and absGFR values were much more determined by the actual recipient weight than by the donor weight (27/6% and 43/4% at discharge, by 24/4% and 57/0% 1 year after TPL, and 0/0% and 20/0% at the end of the follow-up). A tendency for lower eGFR with increasing age of donors was apparent at discharge and 1 year after TPL, but it reached statistical significance only at the last follow-up (r = 0.4254, P < 0.01). CONCLUSION: In paediatric renal transplants, the value of D/R BWR directly correlated with eGFR in the early and late posttransplant periods. However, this correlation was mainly influenced by the recipient weight, while the donor weight played only a minor or negligible role.


Subject(s)
Body Weight , Kidney Failure, Chronic/surgery , Kidney Transplantation/methods , Living Donors , Organ Size , Adolescent , Adult , Age Factors , Child , Child, Preschool , Cohort Studies , Female , Follow-Up Studies , Glomerular Filtration Rate , Graft Rejection , Graft Survival , Humans , Kidney Failure, Chronic/diagnosis , Kidney Function Tests , Kidney Transplantation/adverse effects , Length of Stay , Male , Middle Aged , Retrospective Studies , Risk Assessment , Time Factors , Tissue Donors
2.
Neuro Endocrinol Lett ; 24(5): 304-9, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14647001

ABSTRACT

OBJECTIVES: To study the balance between the pro-oxidative and antioxidative defence system after repeated painful stimulation in rats and the efficacy of the administration of different antioxidants (vitamins C, E, A, and selenium), analgesics (acetylsalicylic acid, morphine), and their combinations. METHODS: Mechanical clamping of both hind limbs was applied for 10 min for 5 consecutive days in adult male Wistar rats. The tail-flick latency was measured before and after a 5-day nociceptive stimulation with or without the substance application. The reactive oxygen species (ROS) were determined in the sensorimotor cortex. RESULTS: Painful stimulation increased lipoperoxidation which persisted for up to 15 days after it had been discontinued. A simultaneous injection of antioxidants decreased the levels of TBARS, SOD and GSHPx; however, antioxidants applied one week prior to the painful stimulation were ineffective. A simultaneous injection of analgesics reduced stress-induced analgesia caused by the nociceptive stimulation, but did not affect lipoperoxidation. CONCLUSIONS: A combination of antioxidants with analgesics normalized both the oxidative stress and functional (the tail-flick latency) indicators. These results suggest that the administration of antioxidants in pain treatment may be employed to decrease the doses of analgesics and to prevent the negative impact of reactive oxygen species on nociception.


Subject(s)
Analgesics/pharmacology , Antioxidants/pharmacology , Ascorbic Acid/pharmacology , Aspirin/pharmacology , Pain/drug therapy , Pain/metabolism , Analgesics, Opioid/pharmacology , Animals , Drug Therapy, Combination , Free Radicals/metabolism , Lipid Peroxidation/drug effects , Male , Morphine/pharmacology , Pain Measurement , Rats , Rats, Wistar , Selenium/pharmacology , Vitamin A/pharmacology , Vitamin E/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...